The China chief of AstraZeneca - Britain's biggest company - was arrested months ago, but his condition and whereabouts remain a mystery ...

Following a successful patent defense case upheld by China’s IP authority, AstraZeneca invested nearly 9 billion yuan ($1.24 billion) to establish two global R&D centres in Beijing and Shanghai, said ...

- A Beijing court this week sentenced a Japanese employee of Astellas Pharma to 3-1/2 years in prison. The man had been ...

Sino Biopharmaceuticals plans to pay up to $950.9 million to acquire LaNova Medicines, which previously licensed drugs to ...

BEIJING: US bank Wells Fargo told AFP Friday it was working to help one of its employees return to the United States, after ...

Top regulators like the US FDA and EMA are fast-tracking more Chinese drugs, granting priority review and breakthrough ...

AstraZeneca (LSE:AZN) received EU approval for its cancer treatment Imfinzi, marking a significant product-related milestone.

Both AstraZeneca and MSD have tied lucrative licensing deals for two of LaNova’s oncology assets in recent years.

Biotech deals involving assets developed in China are surging, a Jefferies report shows. | Biotech deals involving assets ...

HONG KONG] The biotechnology industry is experiencing a tectonic shift, driven by Chinese drugmakers who have come a long way ...

A top Chinese oncologist and physician-scientist, Cheng Ying, has died suddenly aged 62, according to multiple sources. There has been no official statement about the doctor’s death, and the cause of ...

Hiroshi Watanabe/DigitalVision via Getty Images Most major stock indexes across the globe ended the week higher, following ...